Microvalve bioprinting as a tool against tumor
Microvalve Bioprinting technologies are powerful new bioengineering tools that can spatially reproduce multiple microenvironmental cues in a highly controlled, tunable, and precise manner.
In this study, microvalve bioprinting technology was successfully used to print endothelial and tumor cells at higher concentrations, while preservating their viability.
We propose that the resulting multicellular models, bioprinted in a controlled extracellular matrix microenvironment, are well-suited to study endothelial and cancer cell crosstalk within a cancer niche.
In fact, microvalve bioprinting was applied to the bioengineering of a simplified glioblastoma.
In this model, glioblastoma cells and primary human umbilical vein endothelial cells (HUVECs) exhibited high viability after printing.
U251 cells formed physiologically relevant clusters and invasion margins, while HUVECs generated vascular-like networks when primary fibroblasts were added to the model.
Results also suggested that stressed glioblastoma cells may alter normal endothelial cell proliferation but not impact their senescence.
This data demonstrates the potential of microvalve bioprinting to fabricate in vitro models that can help decipher endothelial and tumor cell crosstalk, within controlled and modulable microenvironments.
It also can be used to address critical questions in the context of cancer recurrence.